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a b s t r a c t
In the last years, researches developed with biosurfactants for application in the medical area have been
revealing the promising biological activities of these biomolecules. In this work the antimicrobial and
anti-adhesive properties of a biosurfactant Ruﬁsan isolated from the yeast Candida lipolytica UCP 0988,
growth in a medium supplemented with ground nut reﬁnery residue was determined against several
microorganisms. The biosurfactant was able to reduce the water surface tension from 70 to 25.3mN/m
and showed a critical micelle concentration (CMC) of 0.03%. The biosurfactant was isolated after 72h of
fermentation and was tested in concentrations varying from 0.75 to 12mg/l. The highest antimicrobial
activities were observed against Streptococcus agalactiae, Streptococcus mutans, Streptococcus mutans NS,iosurfactant
nti-adhesive
ntimicrobial
Streptococcus mutans HG, Streptococcus sanguis 12, Streptococcus oralis J22 at a concentration superior to
the biosurfactant critical micelle concentration. Moreover, the biosurfactant showed anti-adhesive activ-
ity against most of the microorganisms tested. As far as we know, this is the ﬁrst compilation of data on
antimicrobial and anti-adhesive activities of a biosurfactant obtained from a Candida strain against such
a broad group of microorganisms. The results obtained in this work showed that the biosurfactant from
C. lipolytica is a potential antimicrobial and/or anti-adhesive agent for several biomedical applications.
 . Introduction
Surfactants, amphiphilic molecules consisting of a polar head
roup and a hydrophobic tail, are the active ingredients found
n soaps and detergents. Due to their ability to concentrate at
he air–water interface, they are commonly used to separate
ily materials from a given medium. Surfactants increase the
queous solubility of hydrophilic molecules by reducing their sur-
ace/interfacial tension at air–water and water–oil interfaces [1,2].
s the interfacial tension is reduced and the aqueous surfac-
ant concentration is increased, the monomers aggregate to form
icelles. The concentration at which micelles ﬁrst begin to forms known as the critical micelle concentration (CMC). This concen-
ration corresponds to the point where the surfactant ﬁrst shows a
table low surface tension value [3].
∗ Corresponding author at: Nucleus of Research in Environmental Sciences,
atholic University of Pernambuco, Rua Nunes Machado, n. 42, Bl J, Térreo, Boa
ista, CEP 50050-590, Recife-Pernambuco, Brazil. Tel.: +55 81 21194044;
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Almost all surfactants being currently produced are chemically
derived from petroleum. However, these synthetic surfactants are
usually toxic themselves and hardly degraded by microorganisms.
They are, therefore, a potential source of pollution and damage to
the environment. These hazards associated with synthetic emulsi-
ﬁers have, in recent years, drawn much attention to the microbial
production of surfactants (biosurfactants) [4].
Biosurfactants are derived from living organisms, mainly
microorganisms, and have attracted much attention because of
advantageous characteristics such as structural diversity, low toxi-
city, higher biodegradability, better environmental compatibility,
higher substrate selectivity, biodegradability, and lower CMC.
These properties have led to several biosurfactant applications in
the food, cosmetic and pharmaceutical industries [5,6].
The most commonly isolated biosurfactants are glycolipids and
lipopeptides. They include rhamnolipids released by Pseudomonas
aeruginosa [7], sophorolipids from Candida species [8], as well as
surfactin and iturin producedbyBacillus subtilis strains [9]. Thepro-
duction yields of these biosurfactants are relatively high (2–10g/l)
Open access under the Elsevier OA license.and they reduce the surface tension of water to values bellow
30mN/m [10]. Furthermore, Candida lipolytica UCP 0988was found
to produce 4.5 g/l of biosurfactant and this polymeric structure was
capable of lowering the surface tension of water values around
32mN/m [11].
2 rfaces
a
a
s
i
f
a
L
s
A
h
t
p
a
n
h
p
m
b
o
e
m
p
t
h
t
2
2
s
r
B
(
s
0
2
m
c
p
l
M
c
J
c
P
d
c
d
w
t
s
g
s
o
W
2
sR.D. Ruﬁno et al. / Colloids and Su
Several biosurfactants exhibit antibacterial, antifungal and
ntiviral activities, which make them relevant molecules for
pplications in combating many diseases and infections [12]. Bio-
urfactantswithknownantimicrobial activity include surfactin and
turin produced by B. subtilis strains [9], mannosylerythritol lipids
rom Candida antarctica [13], rhamnolipids from P. aeruginosa [14]
nd biosurfactants isolated from Streptococcus thermophilus A and
actococcus lactis 53 [15–17]. Another valuable application of bio-
urfactants is their use as anti-adhesive agents against pathogens.
dsorption of biosurfactants to a substratum surface modiﬁes its
ydrophobicity, interfering in the microbial adhesion and desorp-
ion processes [18]; in that sense, the release of biosurfactants by
robiotic bacteria in vivo can be considered as a defence weapon
gainst other colonizing strains in the urogenital and gastrointesti-
al tracts [19]. Biosurfactants produced by Lactobacillus paracasei
ave been shown to reduce adhesion of pathogenic and non-
athogenic microorganisms [20,21].
Considering the lack of studies with yeasts biosurfactants for
edical purposes and the attractive characteristics showed by the
iosurfactant produced by the C. lipolytica strain UCP 0988, the aim
f thisworkwas to study the antimicrobial and anti-adhesive prop-
rties of this biosurfactant against pathogenic and nonpathogenic
icroorganisms. Results gathered in the current work showed the
otential of the biosurfactants in this ﬁeld of application. However,
heir use still remains limited, possibly due to their comparatively
igh production costs, as well as scant information on their toxicity
owards human systems.
. Materials and methods
.1. Microorganisms and growth conditions
The microorganism Candida lipolytica UCP 0988 was kindly
upplied from theCulture Collection ofNucleus of Research in Envi-
onmental Sciences, Catholic University of Pernambuco, Recife-PE,
razil, registered in the World Federation of Culture Collection
WFCC). The microorganism was maintained in an anamorphic
tate at 5 ◦C on Yeast Mold Agar (YMA) slants containing (w/v):
.3% yeast extract, 0.3% malt extract, 0.5% peptone, 1% glucose and
% agar. Transfers were made to fresh agar slants each month to
aintain viability.
Several strains that commonly colonize prostheses and medi-
al devices were used to test the antimicrobial and anti-adhesive
roperties of the biosurfactant. Lactobacillus casei 36, Lactobacil-
us casei 72, Lactobacillus reuteri 104R and Lactobacillus reuteri
L1 were cultured in MRS broth; Streptococcus mutans, Strepto-
occus mutans NS, Streptococcus mutans HG985, Streptococcus oralis
22, Streptococcus sanguis 12, Rothia dentocariosa and Streptococ-
us salivarius were cultured in Todd-Hewitt Broth; Escherichia coli,
seudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epi-
ermidis, Streptococcus agalactiae and Streptococcus pyogenes were
ultured in Trypticase Soy Broth (TSB); Candida albicans and Can-
ida tropicalis were grown in yeast mould broth (YMB) (all media
ereobtained fromOxoid).All the strainsweregrownat37 ◦C,with
he exception of C. albicans and C. tropicalis (30 ◦C). Strains were
tored at −80 ◦C in the appropriate medium containing 15% (v/v)
lycerol solution until they were used. Whenever required, frozen
tocks were streaked on agar plates and incubated overnight at the
ptimumgrowing temperature for each strain for further culturing.
orking stock cultures were kept at 4 ◦C for up to 2 weeks [20]..2. Biosurfactant production
The production medium used for the experiments con-
isted of the following: 0.1% NH4NO3, 0.02% KH2PO4 and 0.02%B: Biointerfaces 84 (2011) 1–5
MgSO4·7H2O. The medium was supplemented with soybean oil
reﬁnery residue and glutamic acid [1]. The reﬁnery residue was
obtained from ASA Indústria e Comércio LTDA (Recife-PE, Brazil).
The composition of the reﬁnery residue was previously described
[22].
The inoculums were prepared in an Erlenmeyer ﬂask with a
capacity of 250ml containing 50ml of YMB and were inoculated
using a microbial loop, incubated in an orbital shaker at 150 rpm
and28 ◦C for 24h. ThepHof the culturemediumwas adjusted to5.7
by addition 1M NaOH solution or 1M HCl solution. All fermenta-
tions were conducted in 250ml Erlenmeyer ﬂasks containing 50ml
of the production medium. Immediately after inoculation of 5% of
108 cells/ml, the ﬂasks were incubated for 72h at 28 ◦C in an orbital
shaker at 150 rpm.
2.3. Isolation of biosurfactant
The72hculturewasﬁltered throughWhatmanNo. 1ﬁlterpaper
and centrifuged at 5000× g for 20min. The cell-free broth was con-
centrated (500ml) by freeze-drying and extracted two times with
chloroform (1:1, by vol.) in a separator funnel at 28 ◦C [23].
2.4. Surface activity
Surface tension was determined on cell-free broth obtained by
centrifuging the cultures at 5000× g for 20min with a Tensiometer
model Sigma 70 (KSV Instruments LTD, Finland) using the Du Nouy
ring method at room temperature.
2.5. Critical micelle concentration (CMC)
The surface tension was measured by the ring method using
a DuNouy Tensiometer model Sigma 70 (KSV Instruments LTD,
Finland) at room temperature. The concentration at which micelles
began to form was represented as the CMC. At the CMC, sudden
changes in surface tension, electrical conductivity and detergency
were observed. The CMC was automatically determined by mea-
suring the surface tensions of the puriﬁed biosurfactant in distilled
water up to a constant value of surface tension.
2.6. Antimicrobial assays
The antimicrobial activity of the crude biosurfactant produced
by C. lipolytica UCP 0988 against several microbial strains was
determined by the microdilution method in 96-well ﬂat-bottom
plastic tissue culture plates (Greiner Bio-One GmbH, Fricken-
hausen, Germany) [20].
For each strain, appropriate medium and temperature were
used (as previously described); brieﬂy, 125l of sterile, double-
strength culture medium were placed into the ﬁrst column of
the 96-well microplate and 125l of sterile, single-strength cul-
ture medium in the remaining wells. Subsequently, 125l of
biosurfactant solution in phosphate buffer saline at a 100mg/ml
concentration (PBS: 10 mM KH2PO4/K2HPO4 and 150mM NaCl
with pH adjusted to 7.0) (100mg/ml) were added to the ﬁrst col-
umn of the microplate and mixed with the medium; this results
in a biosurfactant concentration of 50mg/ml; serially, 125l were
transferred to the subsequent wells, discarding 125l of the mix-
ture in the tenth column, so that the ﬁnal volume for each well
was 125l. This process results in twofold serial dilutions of the
biosurfactant in the ﬁrst 10 columns (50–0.09mg/ml). Columns 11
and 12 did not contain biosurfactant and served as negative and
growth controls, respectively. All the wells (except for the 11th
column) were inoculated with 2.5l of an overnight culture at
the deﬁned optimumconditions, diluted to 108 cfu/ml.Microplates
were covered and incubated for 48h under the appropriate growth
rfaces B: Biointerfaces 84 (2011) 1–5 3
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onditions for each microorganism. Triplicate assays were per-
ormed for all biosurfactant concentrations used for each strain.
After 48h of incubation, the absorbance at 600nm was deter-
ined for each well. The growth inhibition percentages at different
iosurfactant concentrations for each microorganism were calcu-
ated as (Eq. (1)):
Growth inhibitionc =
[
1 −
(
Ac
A0
)]
× 100 (1)
hereAc represents the absorbance of thewellwith a biosurfactant
oncentration c and A0 the absorbance of the control well (without
iosurfactant) [20].
.7. Anti-adhesion assays
The anti-adhesive activity of the crude biosurfactant isolated
rom C. lipolytica UCP 0988 against several microbial strains was
uantiﬁed according to the procedure described by Heinemann
t al. [24]. Brieﬂy, the wells of a sterile 96-well ﬂat-bottom
olystyrene tissue culture plate (Greiner Bio-One GmbH) were
lled with 200l of the crude biosurfactant. Several biosurfactant
oncentrations were tested ranging from 3 to 50mg/ml. The plate
as incubated for 18h at 4 ◦C and subsequently washed twice with
BS. Control wells contained PBS buffer only. An aliquot of 200l
f a washed bacterial or yeast suspension (108 cfu/ml) was added
nd incubated in the wells for 4h at 4 ◦C. Unattached microorgan-
sms were removed by washing the wells three times with PBS.
he adherent microorganisms were ﬁxed with 200l of methanol
99% purity) per well, and after 15min, the plates were emptied
nd left to dry. Then the plates were stained for 5min with 200l
f 2% crystal violet used for Gram staining per well. Excess stain
as rinsed out by placing the plate under running tap water. Sub-
equently, the plates were air dried, the dye bound to the adherent
icroorganisms was resolubilized with 200l of 33% (v/v) glacial
cetic acid per well, and the absorbance of each well was measured
t 595nm. Themicrobial inhibition percentages at different biosur-
actant concentrations for each microorganism were calculated as
Eq. (2)):
Microbial inhibitionc =
[
1 −
(
Ac
A0
)]
× 100 (2)
here Ac represents the absorbance of the well with a biosurfac-
ant concentration c and A0 the absorbance of the control well. The
icrotitre-plate anti-adhesion assay estimates the percentage of
icrobial adhesion reduction in relation to the controlwells,which
ere set at 0% to indicate the absence of biosurfactant and there-
oreof its anti-adhesionproperties. In contrast, negativepercentage
esults indicate the percentage increase in microbial adhesion at
given surfactant concentration in relation to the control. The
icrotitre-plate anti-adhesion assay allows the estimation of the
rude biosurfactant concentrations that are effective in decreasing
dhesion of the microorganisms studied.
. Results and discussion
.1. Yield, surface tension and critical micelle concentration of
he biosurfactant
The yield of the crude biosurfactant produced by C. lipolytica
CP 0988 grown on industrial reﬁnery residue after 72h was 8g/l.
he biosurfactant was able to reduce the medium surface tension
rom 50.0mN/m to 25.0mN/m. On the other hand, Candida bombi-
olagrownonglucose andarachidonic acidproduced sophorolipids
p to 1.44g/l after 96h [25], while C. lipolytica grown on indus-
rial reﬁnery residue produced 4.5 g/l of biosurfactant after 144hFig. 1. Surface tension versus concentration of the isolated biosurfactant produced
by Candida lipolytica UCP 0988 grown in medium supplemented with soybean oil
reﬁnery residue and glutamic acid.
[11]. The biosurfactants produced by yeasts described in the lit-
erature also show low surface tension values as the biosurfactant
from C. lipolytica (32mN/m) [11], from Candida glabrata (31mN/m)
[26], from C. antarctica (35mN/m) [27] and from Yarrowia lipolytica
(50mN/m) [28].
The CMC is a widely used index to evaluate surface activity. By
deﬁnition, the CMC is the surfactant concentration of surfactant
above which micelles are spontaneously formed. Until the CMC is
reached a decrease in the surface tension will be observed. How-
ever, upon reaching the CMC, any further increase in the surfactant
concentration will only increase the number of micelles and no
alteration in the surface tension will be observed [29].
The relationship between surface tension and concentration of
the isolated biosurfactant solutionwas determined in an automatic
tensiometer (Fig. 1). The biosurfactant exhibited excellent surface
tension reducing activity. The surface tension of water of 71mN/m
decreased to 25.0mN/m by increasing the solution concentration
up to 3mg/l. Further increase in the concentration of the biosurfac-
tant solution did not reduce the surface tension ofwater, indicating
that the CMC was reached at this concentration.
The biosurfactant produced by C. lipolytica showed CMC val-
ues of 2.5% [30], while the biosurfactant from C. antarctica
showed a concentration of 0.6% mg/l at the CMC [27]. The
biosurfactant produced by Lactobacillus paracasei exhibited a min-
imum surface tension value of 41.8mN/m for a concentration of
50mg/ml [21].
3.2. Antimicrobial activity
Several biosurfactants which exhibit antimicrobial activity
against various microorganisms have been previously described.
They include surfactin and iturin produced by Bacillus subtilis
strains [9], rhamnolipids from Pseudomonas species [14,31], man-
nosylerythritol lipids from C. antarctica [13] and biosurfactants
produced by some fungi [32].
The antimicrobial activity of the crude biosurfactant isolated
from Candida lipolytica UCP 0988 was determined by measuring
the growth inhibition percentages obtained for several microor-
ganisms (Table 1).
The biosurfactant was effective against the microorganisms
tested, albeit to different degrees. The highest anti-adhesive per-
centageswereobtained for abiosurfactant concentrationof 12mg/l
or 4×CMC. Non-pathogenic species associated with the oral cavity
4 R.D. Ruﬁno et al. / Colloids and Surfaces B: Biointerfaces 84 (2011) 1–5
Table 1
Percentages of growth inhibition obtained with the biosurfactant isolated from Candida lipolytica UCP 0988 at different concentrations (mg/l). Results are expressed as
means± standard deviations of values obtained from triplicate experiments.
Microorganism Growth inhibition (%)
Biosurfactant (mg/l)
0.75 1.5 3 6 12
Lactobacillus casei 4.5 ± 0.02 9.1 ± 0.07 15 ± 0.02 27.2 ± 0.08 28.4 ± 0.05
Lactobacillus casei 72 4.5 ± 0.03 14.2 ± 0.08 18.1 ± 0.06 32.9 ± 0.06 33.7 ± 0.03
Lactobacillus reuteri 104R 5.9 ± 0.07 9.7 ± 0.01 15.5 ± 0.01 24.4 ± 0.05 25.4 ± 0.08
Lactobacillus reuteri ML1 8.2 ± 0.06 11.3 ± 0.02 16.3 ± 0.02 31.1 ± 0.02 32.1 ± 0.02
Escherichia coli 0 0 3.0 ± 0.01 5.0 ± 0.01 5.0 ± 0.01
Streptococcus agalactiae 0 10.9 ± 0.03 35.3 ± 0.03 35.8 ± 0.02 35.5 ± 0.02
Streptococcus mutans NS 15.6 ± 0.07 20.1 ± 0.04 23.8 ± 0.13 46.0 ± 0.1 46.4 ± 0.01
Streptococcus sanguis 12 13.7 ± 0.07 21.5 ± 0.04 31.7 ± 0.05 48.1 ± 0.08 48.0 ± 0.01
Streptococcus mutans 22.5 ± 0.02 34.8 ± 0.01 44.6 ± 0.01 58.3 ± 0.01 58.0 ± 0.06
Streptococcus oralis J22 12.8 ± 0.04 13.2 ± 0.03 14.2 ± 0.03 18.7 ± 0.08 62.8 ± 0.06
Streptococcus mutans HG985 41.8 ± 0.02 43.1 ± 0.01 55.6 ± 0.04 64.6 ± 0.03 64.9 ± 0.01
o
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ePseudomonas aeruginosa 0 7.9 ± 0.02
Staphylococcus aureus 0 0
Staphylococcus epidermidis 10.1 ± 0.01 12.9 ± 0.07
Candida albicans 0 0
f Streptococcus were used (S. mutans HG – 64.9%; S. oralis J22 –
2.8%; S. mutans – 58%; S. sanguis 12 – 48%; S. mutans NS – 46%). On
he other hand, the biosurfactant did not show an effective antimi-
robial activity against the Lactobacillus strains studied. It inhibited
nly 32.1% of the growth of L. reuteri ML1 at the maximum concen-
ration tested (12mg/l).
The growth of the other microorganisms tested was poorly
nhibited. Percentages of 5%, 5%, 15%, 16% and 18% were observed
or C. albicans, E. coli, S. aureus, P. aeruginosa and S. epidermidis,
espectively.
.3. Anti-adhesive activity
Involvement of biosurfactants in microbial adhesion and des-
rptionhasbeenwidelydescribed, andadsorptionofbiosurfactants
o solid surfaces might constitute an effective strategy to reduce
icrobial adhesion and combating colonization by pathogenic
icroorganisms, not only in the biomedical ﬁeld, but also in otherreas, such as the food industry [16,33–35].
In addition to the antimicrobial properties, the anti-adhesive
ctivity of the biosurfactant was evaluated against a variety
f bacterial and fungal strains. The biosurfactant showed anti-
dhesive activity against most of the microorganisms tested, but
able 2
nti-adhesive properties of crude biosurfactant isolated from Candida lipolytica UCP 0988
ercentages indicate the reductions in microbial adhesion when compared to the contr
xperiments.
Microorganism Antiadhesive Activity (%)
Biosurfactant (mg/l)
0.75 1.5
Lactobacillus casei 91 ± 0.1 91 ± 0.1
Lactobacillus casei 72 81 ± 0.0 87 ± 0.0
Lactobacillus reuteri 104R 84 ± 0.2 93 ± 0.2
Lactobacillus reuteri ML1 81 ± 0.0 82 ± 0.0
Escherichia coli 8 ± 0.1 17 ± 0.1
Streptococcus agalactiae 80 ± 0.0 81 ± 0.0
Streptococcus mutans NS 91 ± 0.1 95 ± 0.1
Streptococcus sanguis 12 61 ± 0.0 62 ± 0.0
Streptococcus mutans 76 ± 0.1 84 ± 0.1
Streptococcus oralis J22 73 ± 0.0 85 ± 0.0
Streptococcus mutans HG985 76 ± 0.1 76 ± 0.1
Pseudomonas aeruginosa 13 ± 0.0 26 ± 0.0
Staphylococcus aureus 88 ± 0.0 91 ± 0.0
Staphylococcus epidermidis 2 ± 0.0 5 ± 0.0
Candida albicans 8 ± 0.0 8 ± 0.010 ± 0.01 11.6 ± 0.01 16.5 ± 0.04
1.57 ± 0.06 3.15 ± 0.06 15.1 ± 0.03
14.9 ± 0.07 18.1 ± 0.01 18.0 ± 0.06
3.1 ± 0.03 5.95 ± 0.01 6.0 ± 0.02
the anti-adhesive effect depends on the concentration and the
micro-organism tested (Table 2).
The crude biosurfactant showed anti-adhesive activity against
most of the microorganisms tested from the minimum concentra-
tion used (0.75mg/l). The anti-adhesive property was proportional
to the concentration of the biosurfactant. For the microorganisms
of the Lactobacillus anti-adhesive values around 81%were observed
at the minor concentration tested (0.75mg/l). The major anti-
adhesive speciﬁcity was observed against L. casei with values of
91% and 99% with the minimum concentration used. Low inhibi-
tions were observed for S. epidermidis and E. coli, with values of
27% and 21%, respectively, at the maximum biosurfactant concen-
tration. For the other microorganisms, the anti-adhesive activity
was above 45%.
Gudina et al. [21] observed an anti-adhesive activity for the bio-
surfactant from Lactobacillus paracasei against several pathogenic
microorganisms such as S. aureus, S. epidermidis and S. agalac-
tiae. However, this biosurfactant showed lowanti-adhesive activity
against E. coli, C. albicans and P. aeruginosa, in contrast with the
antimicrobial activity exhibited against these strains at the same
biosurfactant concentrations.
The use and potential commercial applications of biosurfac-
tants in the medical ﬁeld has increased considerably in the last
. Negative controls were set at 0% to indicate the absence of biosurfactant. Positive
ol. Results are expressed as means± standard deviation of results from triplicate
3 6 12 Control (PBS)
99 ± 0.1 99 ± 0.1 99 ± 0.1 0
89 ± 0.0 91 ± 0.0 95 ± 0.0 0
94 ± 0.2 95 ± 0.2 97 ± 0.2 0
84 ± 0.0 87 ± 0.0 89 ± 0.0 0
18 ± 0.1 25 ± 0.1 27 ± 0.1 0
81 ± 0.0 84 ± 0.0 96 ± 0.0 0
96 ± 0.1 98 ± 0.1 99 ± 0.1 0
68 ± 0.0 70 ± 0.0 77 ± 0.0 0
85 ± 0.1 88 ± 0.1 97 ± 0.1 0
87 ± 0.0 89 ± 0.0 90 ± 0.0 0
81 ± 0.1 83 ± 0.1 85 ± 0.1 0
33 ± 0.0 41 ± 0.0 49 ± 0.0 0
92 ± 0.0 97 ± 0.0 98 ± 0.0 0
6 ± 0.0 16 ± 0.0 21 ± 0.0 0
16 ± 0.0 36 ± 0.0 51 ± 0.0 0
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ears. Their antimicrobial and anti-adhesive properties make them
elevant molecules for use in combating many diseases and infec-
ions and as therapeutic agents [36]. Falagas and Makris [35] have
roposed the application of biosurfactants isolated from probiotic
acteria to patient care equipments (such as catheters and other
edical insertional devices) inhospitals,with the aimofdecreasing
olonization by microorganisms responsible for nosocomial infec-
ions.
. Conclusions
In conclusion, in this work we have demonstrated the antimi-
robial and anti-adhesive properties of the crude biosurfactant
solated from C. lipolytica UCP 0988 against several pathogenic and
onpathogenic microorganisms, including bacteria, yeasts and ﬁl-
mentous fungi. The results obtained suggest the possible use of
his biosurfactant as an alternative antimicrobial agent in the med-
cal ﬁeld for applications against microorganisms responsible for
iseases and infections, making it a suitable alternative to conven-
ional antibiotics.
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